Diagnostic gene-sequencing has been employed to avoid RyR1-related congenital myopathies, and several disease-modulating therapeutic strategies and salvage therapies have been developed against RyR1-related myopathies [10–15]. This evidence concerns the gene RYR1 and myopathy.